Contec Medical Systems Co.,Ltd (SHE:300869)

SHE:300869 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	747.38	684.31	470.53	1,393	623.98	814.07
Short-Term Investments	-	252.03	840.82	486.27	189.98	-
Trading Asset Securities	672.31	171.59	652.02	46.64	-	-
Cash & Short-Term Investments	1,420	1,108	1,963	1,926	813.96	814.07
Cash Growth	-13.11%	-43.57%	1.96%	136.57%	-0.01%	341.70%
Accounts Receivable	45.68	46	39.86	160.75	66.21	101.67
Other Receivables	13.13	7.34	7.09	13.76	39.88	4.05
Receivables	58.81	533.58	46.96	174.52	106.09	105.71
Inventory	265.88	272.32	463.23	430.24	418.69	284.42
Prepaid Expenses	-	1.21	1.78	1.42	4.08	1.37
Other Current Assets	400.36	6.18	6.83	26.64	9.31	61.62
Total Current Assets	2,145	1,921	2,482	2,558	1,352	1,267
Property, Plant & Equipment	333.36	336.07	290.76	275.13	226.09	151.14
Long-Term Investments	-	403.95	360.47	298.04	1,156	636.96
Other Intangible Assets	51.4	52.07	54.74	57.47	33.61	13.07
Long-Term Deferred Tax Assets	4.95	3.78	5.8	1.81	0.73	3.73
Long-Term Deferred Charges	0.07	0.07	-	-	-	-
Other Long-Term Assets	252.88	8.36	18	541.93	20.63	25.72
Total Assets	2,787	2,726	3,212	3,733	2,789	2,098
Accounts Payable	14.45	18.39	17.79	54.3	47.62	93.36
Accrued Expenses	17.31	12.93	15.68	32.69	15.95	17.03
Short-Term Debt	91.44	60	347	903.37	800.39	267.94
Current Portion of Leases	-	1.71	3.16	1.67	1.15	-
Current Income Taxes Payable	-	0.24	26.1	18.81	37.65	95.12
Current Unearned Revenue	42.56	32.04	39.97	76.6	45.61	38.57
Other Current Liabilities	6.62	9.48	10.25	25.11	7.27	2.91
Total Current Liabilities	172.38	134.79	459.94	1,113	955.64	514.92
Long-Term Debt	731.81	723.52	695.57	666.94	-	-
Long-Term Leases	1.49	1.83	2.72	4.06	2.79	-
Long-Term Unearned Revenue	7.61	7.81	8.92	9.07	9.76	11.58
Long-Term Deferred Tax Liabilities	0.14	0.15	0	11.85	0.8	2.5
Total Liabilities	913.42	868.1	1,167	1,804	968.99	529
Common Stock	401.8	401.8	401.8	401.8	401.8	401.8
Additional Paid-In Capital	352.34	352.34	345.14	344.98	344.98	344.98
Retained Earnings	1,087	1,070	1,265	1,150	1,074	822.2
Comprehensive Income & Other	33.08	32.94	32.54	31.79	-0.82	-0.15
Shareholders' Equity	1,874	1,857	2,045	1,928	1,820	1,569
Total Liabilities & Equity	2,787	2,726	3,212	3,733	2,789	2,098
Total Debt	824.73	787.07	1,048	1,576	804.33	267.94
Net Cash (Debt)	594.96	320.85	914.91	349.56	9.63	546.13
Net Cash Growth	-13.56%	-64.93%	161.73%	3529.53%	-98.24%	230.13%
Net Cash Per Share	1.45	0.78	2.21	0.86	0.02	1.46
Filing Date Shares Outstanding	401.85	401.8	401.8	401.8	401.8	401.8
Total Common Shares Outstanding	401.85	401.8	401.8	401.8	401.8	401.8
Working Capital	1,972	1,786	2,022	1,446	396.5	752.27
Book Value Per Share	4.66	4.62	5.09	4.80	4.53	3.90
Tangible Book Value	1,823	1,805	1,990	1,871	1,786	1,556
Tangible Book Value Per Share	4.54	4.49	4.95	4.66	4.45	3.87
Buildings	-	245.65	226.46	232.82	142.81	142.18
Machinery	-	181.12	169.29	147.98	125.88	90.26
Construction In Progress	-	72.85	24.55	1.32	51.22	3.86

Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.